Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Assessment of pathological response to therapy using lipid mass spectrometry imaging.

Patterson NH, Alabdulkarim B, Lazaris A, Thomas A, Marcinkiewicz MM, Gao ZH, Vermeulen PB, Chaurand P, Metrakos P.

Sci Rep. 2016 Nov 14;6:36814. doi: 10.1038/srep36814.

2.

Comparison of Anatomical and Nonanatomical Hepatectomy for Colorectal Liver Metastasis: A Meta-Analysis of 5207 Patients.

Tang H, Li B, Zhang H, Dong J, Lu W.

Sci Rep. 2016 Aug 31;6:32304. doi: 10.1038/srep32304.

3.

Hepatic resection margin predicts survival in colorectal cancer with hepatic metastasis.

Choi JH, Yoon MH.

Korean J Hepatobiliary Pancreat Surg. 2012 May;16(2):55-8. doi: 10.14701/kjhbps.2012.16.2.55. Epub 2012 May 31.

4.

Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.

Araujo RL, Gönen M, Allen P, DeMatteo R, Kingham P, Jarnagin W, D'Angelica M, Fong Y.

Ann Surg Oncol. 2015 Sep;22(9):3087-93. doi: 10.1245/s10434-014-4358-2. Epub 2015 Jan 13.

5.

History and present status of pulmonary metastasectomy in colorectal cancer.

Treasure T, Milošević M, Fiorentino F, Pfannschmidt J.

World J Gastroenterol. 2014 Oct 28;20(40):14517-26. doi: 10.3748/wjg.v20.i40.14517. Review.

6.

Surgery for colorectal liver metastases: The evolution of determining prognosis.

Spolverato G, Ejaz A, Azad N, Pawlik TM.

World J Gastrointest Oncol. 2013 Dec 15;5(12):207-21. doi: 10.4251/wjgo.v5.i12.207. Review.

7.

Liver resection after chemotherapy and tumour downsizing in patients with initially unresectable colorectal cancer liver metastases.

Devaud N, Kanji ZS, Dhani N, Grant RC, Shoushtari H, Serrano PE, Nanji S, Greig PD, McGilvray I, Moulton CA, Wei A, Gallinger S, Cleary SP.

HPB (Oxford). 2014 May;16(5):475-80. doi: 10.1111/hpb.12159. Epub 2013 Aug 9.

8.

Patient selection for hepatic resection for metastatic colorectal cancer.

Weiss MJ, D'Angelica MI.

J Gastrointest Oncol. 2012 Mar;3(1):3-10. doi: 10.3978/j.issn.2078-6891.2012.001. No abstract available.

9.

Colorectal cancer: from epidemiology to current treatment.

Bendardaf R.

Libyan J Med. 2006 Jul 28;1(1):42-59. doi: 10.4176/060714. No abstract available.

10.

Long-term outcome after sequential resections of liver and lung metastases from colorectal carcinoma.

Marudanayagam R, Ramkumar K, Shanmugam V, Langman G, Rajesh P, Coldham C, Bramhall SR, Mayer D, Buckels J, Mirza DF.

HPB (Oxford). 2009 Dec;11(8):671-6. doi: 10.1111/j.1477-2574.2009.00115.x.

11.

Prognostic factors and time-related changes influence results of colorectal liver metastases surgical treatment: a single-center analysis.

Martí J, Modolo MM, Fuster J, Comas J, Cosa R, Ferrer J, Molina V, Romero J, Fondevila C, Charco R, García-Valdecasas JC.

World J Gastroenterol. 2009 Jun 7;15(21):2587-94.

12.
13.

Liver resection in a patient with concomitant thoraco-abdominal and cerebral aneurysms.

Jiao LR, Tysome JR, Navarra G, Habib NA.

HPB (Oxford). 2005;7(1):73-6. doi: 10.1080/13651820410033643.

14.

The impact of margins on outcome after hepatic resection for colorectal metastasis.

Are C, Gonen M, Zazzali K, Dematteo RP, Jarnagin WR, Fong Y, Blumgart LH, D'Angelica M.

Ann Surg. 2007 Aug;246(2):295-300.

15.

Proposal of a new and simple staging system of colorectal liver metastasis.

Nagashima I, Takada T, Nagawa H, Muto T, Okinaga K.

World J Gastroenterol. 2006 Nov 21;12(43):6961-5.

16.
17.

Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases.

Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, Curley SA, Loyer EM, Muratore A, Mentha G, Capussotti L, Vauthey JN.

Ann Surg. 2005 May;241(5):715-22, discussion 722-4.

18.

Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET).

Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA, Strasberg SM.

Ann Surg. 2004 Sep;240(3):438-47; discussion 447-50.

19.

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis.

Gazelle GS, Hunink MG, Kuntz KM, McMahon PM, Halpern EF, Beinfeld M, Lester JS, Tanabe KK, Weinstein MC.

Ann Surg. 2003 Apr;237(4):544-55. Review.

20.

Prognostic significance of dysadherin expression in advanced colorectal carcinoma.

Aoki S, Shimamura T, Shibata T, Nakanishi Y, Moriya Y, Sato Y, Kitajima M, Sakamoto M, Hirohashi S.

Br J Cancer. 2003 Mar 10;88(5):726-32.

Supplemental Content

Support Center